The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Deubiquitylation and regulation of the immune response
Open accessAbstract
Ubiquitylation is a fundamental mechanism of signal transduction that regulates immune responses and many other biological processes. Similar to phosphorylation, ubiquitylation is a reversible process that is counter-regulated by ubiquitylating enzymes and deubiquitylating enzymes (DUBs). Despite the identification of a large number of DUBs, our knowledge of the function and activities of this family of enzymes is just starting to accumulate. As described in this Review, recent studies of several DUBs, in particular CYLD and A20, show that deubiquitylation has an important role in the regulation of both innate and adaptive immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
Gack, M. U., Shin, Y. C., Joo, C.-H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., et al. (2007) · Nature · doi:10.1038/nature05732 · Cited by 1,695
Positive and negative selection of T cells
Starr, T. K., Jameson, S. C., & Hogquist, K. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141107 · Cited by 1,601
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,000
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Profound block in thymocyte development in mice lacking p56lck
Molina, T. J., Kishihara, K., Siderovskid, D. P., van Ewijk, W., Narendran, A., Timms, E., Wakeham, A., Paige, C. J., Hartmann, K.-U., Veillette, A., et al. (1992) · Nature · doi:10.1038/357161a0 · Cited by 970
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., et al. (2006) · Nature · doi:10.1038/nature04369 · Cited by 968
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., & Cheng, G. (2006) · Nature · doi:10.1038/nature04374 · Cited by 881
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
Self-citationA CENTRAL ROLE FOR CENTRAL TOLERANCE
Kyewski, B., & Klein, L. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115601 · Cited by 748
Ubiquitylation and cell signaling
Haglund, K., & Dikic, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600808 · Cited by 734
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
Palacios, E. H., & Weiss, A. (2004) · Oncogene · doi:10.1038/sj.onc.1208074 · Cited by 714
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. (2002) · Nature Immunology · doi:10.1038/ni842 · Cited by 693
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Functions of NF-κB1 and NF-κB2 in immune cell biology
BEINKE, S., & LEY, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040544 · Cited by 610
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 608
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., & Ballard, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11259 · Cited by 554
Bcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527
Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French, D. M., Grewal, I. S., Cochran, A. G., Gordon, N. C., Yin, J., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00425-9 · Cited by 477
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Baccala, R., Hoebe, K., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2007) · Nature Medicine · doi:10.1038/nm1590 · Cited by 473
Triggering the Innate Antiviral Response through IRF-3 Activation
Hiscott, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700002200 · Cited by 458
Ubiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 457
A Deubiquitinase That Regulates Type I Interferon Production
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007) · Science · doi:10.1126/science.1145918 · Cited by 452
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434
Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice
Murphy, M. A., Schnall, R. G., Venter, D. J., Barnett, L., Bertoncello, I., Thien, C. B. F., Langdon, W. Y., & Bowtell, D. D. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4872 · Cited by 360
Hitotsumatsu, O., Ahmad, R.-C., Tavares, R., Wang, M., Philpott, D., Turer, E. E., Lee, B. L., Shiffin, N., Advincula, R., Malynn, B. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.002 · Cited by 347
Altered thymic positive selection and intracellular signals in Cbl-deficient mice
Naramura, M., Kole, H. K., Hu, R.-J., & Gu, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15547 · Cited by 336
The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice
Perry, W. L., Hustad, C. M., Swing, D. A., O'Sullivan, T. N., Jenkins, N. A., & Copeland, N. G. (1998) · Nature Genetics · doi:10.1038/ng0298-143 · Cited by 334
The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways
Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J., & Lin, R. (2007) · Nature Immunology · doi:10.1038/ni1465 · Cited by 318
Regulation of immunity by self-reactive T cells
Kronenberg, M., & Rudensky, A. (2005) · Nature · doi:10.1038/nature03725 · Cited by 309
Beyaert, R., Heyninck, K., & Van Huffel, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00404-4 · Cited by 301
Makarova, K. S., Aravind, L., & Koonin, E. V. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01530-3 · Cited by 282
Shembade, N., Harhaj, N. S., Parvatiyar, K., Copeland, N. G., Jenkins, N. A., Matesic, L. E., & Harhaj, E. W. (2008) · Nature Immunology · doi:10.1038/ni1563 · Cited by 278
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277
Komander, D., Lord, C. J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A., & Barford, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.018 · Cited by 276
Otubains: a new family of cysteine proteases in the ubiquitin pathway
Balakirev, M. Y., Tcherniuk, S. O., Jaquinod, M., & Chroboczek, J. (2003) · EMBO reports · doi:10.1038/sj.embor.embor824 · Cited by 275
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20
Turer, E. E., Tavares, R. M., Mortier, E., Hitotsumatsu, O., Advincula, R., Lee, B., Shifrin, N., Malynn, B. A., & Ma, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071108 · Cited by 271
Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D., & Flavell, R. A. (2006) · Nature Immunology · doi:10.1038/ni1355 · Cited by 262
Immunity by ubiquitylation: a reversible process of modification
Liu, Y.-C., Penninger, J., & Karin, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1731 · Cited by 257
Reiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L., Zhang, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062694 · Cited by 254
Self-citationABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB
Mauro, C., Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P., & Leonardi, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601502200 · Cited by 250
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245
Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response
Hiscott, J. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.002 · Cited by 239
EVANS, P. C., OVAA, H., HAMON, M., KILSHAW, P. J., HAMM, S., BAUER, S., PLOEGH, H. L., & SMITH, T. S. (2004) · Biochemical Journal · doi:10.1042/bj20031377 · Cited by 229
Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins
Wagner, S., Carpentier, I., Rogov, V, Kreike, M., Ikeda, F., Löhr, F., Wu, C.-J., Ashwell, J. D., Dötsch, V, Dikic, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211042 · Cited by 223
Modulation of the Interferon Antiviral Response by the TBK1/IKKi Adaptor Protein TANK
Guo, B., & Cheng, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700017200 · Cited by 223
COP9 signalosome revisited: a novel mediator of protein degradation
Schwechheimer, C., & Deng, X.-W. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02091-8 · Cited by 217
Lin, R., Yang, L., Nakhaei, P., Sun, Q., Sharif-Askari, E., Julkunen, I., & Hiscott, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510326200 · Cited by 215
NF-κB Suppression by the Deubiquitinating Enzyme Cezanne
Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. E., & Evans, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708690200 · Cited by 213
Regulation of Early Wave of Germ Cell Apoptosis and Spermatogenesis by Deubiquitinating Enzyme CYLD
Wright, A., Reiley, W. W., Chang, M., Jin, W., Lee, A. J., Zhang, M., & Sun, S.-C. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.09.007 · Cited by 212
Self-citationMalt1 ubiquitination triggers NF‐κB signaling upon T‐cell activation
Oeckinghaus, A., Wegener, E., Welteke, V., Ferch, U., Arslan, S. Ç., Ruland, J., Scheidereit, C., & Krappmann, D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601897 · Cited by 207
TRAF6 is a T cell–intrinsic negative regulator required for the maintenance of immune homeostasis
King, C. G., Kobayashi, T., Cejas, P. J., Kim, T., Yoon, K., Kim, G. K., Chiffoleau, E., Hickman, S. P., Walsh, P. T., Turka, L. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1449 · Cited by 206
Yoshida, H., Jono, H., Kai, H., & Li, J.-D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509526200 · Cited by 199
Regulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C., & Sun, S.-C. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 198
Self-citationCSN controls NF‐κB by deubiquitinylation of IκBα
Schweitzer, K., Bozko, P. M., Dubiel, W., & Naumann, M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601600 · Cited by 197
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
Self-citationRegulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation
Reiley, W., Zhang, M., Wu, X., Granger, E., & Sun, S.-C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.3886-3895.2005 · Cited by 193
Self-citationShembade, N., Harhaj, N. S., Liebl, D. J., & Harhaj, E. W. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601823 · Cited by 191
The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes
Rawlings, D. J., Sommer, K., & Moreno-García, M. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1944 · Cited by 190
A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling
Saitoh, T., Yamamoto, M., Miyagishi, M., Taira, K., Nakanishi, M., Fujita, T., Akira, S., Yamamoto, N., & Yamaoka, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1507 · Cited by 182
Essential Role of Sequestosome 1/p62 in Regulating Accumulation of Lys63-ubiquitinated Proteins
Wooten, M. W., Geetha, T., Babu, J. R., Seibenhener, M. L., Peng, J., Cox, N., Diaz-Meco, M.-T., & Moscat, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709496200 · Cited by 182
Structure of the A20 OTU domain and mechanistic insights into deubiquitination
Komander, D., & Barford, D. (2008) · Biochemical Journal · doi:10.1042/bj20071399 · Cited by 170
Two isoforms of otubain 1 regulate T cell anergy via GRAIL
Soares, L., Seroogy, C., Skrenta, H., Anandasabapathy, N., Lovelace, P., Chung, C. D., Engleman, E., & Fathman, C. G. (2004) · Nature Immunology · doi:10.1038/ni1017 · Cited by 167
Molecular Basis for the Unique Deubiquitinating Activity of the NF-κB Inhibitor A20
Lin, S.-C., Chung, J. Y., Lamothe, B., Rajashankar, K., Lu, M., Lo, Y.-C., Lam, A. Y., Darnay, B. G., & Wu, H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.092 · Cited by 162
A Novel Type of Deubiquitinating Enzyme
Evans, P. C., Smith, T. S., Lai, M.-J., Williams, M. G., Burke, D. F., Heyninck, K., Kreike, M. M., Beyaert, R., Blundell, T. L., & Kilshaw, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301863200 · Cited by 161
Signaling Through Monoubiquitination
Sigismund, S., Polo, S., & Fiore, P. P. D. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69494-6_6 · Cited by 157
Essential role of TAK1 in thymocyte development and activation
Liu, H.-H., Xie, M., Schneider, M. D., & Chen, Z. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603089103 · Cited by 157
Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation
Iha, H., Péloponèse, J., Verstrepen, L., Zapart, G., Ikeda, F., Smith, C. D., Starost, M. F., Yedavalli, V. R. K., Heyninck, K., Đikić, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.5 · Cited by 155
VALCK, D. D., Jin, D., Heyninck, K., de Craen, M. V., Contreras, R., Fiers, W., Jeang, K., & Beyaert, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202787 · Cited by 140
The tumor suppressor CYLD regulates entry into mitosis
Stegmeier, F. P., Sowa, M. E., Nalepa, G., Gygi, S. P., Harper, J. W., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703268104 · Cited by 137
Negative regulation of Lck by Cbl ubiquitin ligase
Rao, N. L., Miyake, S., Reddi, A. L., Douillard, P., Ghosh, A. K., Dodge, I. L., Zhou, P., Fernandes, N. D., & Band, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062055999 · Cited by 135
Regulation of IκB Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD
Zhang, M., Wu, X., Lee, A. J., Jin, W., Chang, M., Wright, A., Imaizumi, T., & Sun, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801451200 · Cited by 131
Self-citationControl of B Lymphocyte Apoptosis by the Transcription Factor NF-κB
Sen, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.12.003 · Cited by 129
The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration
Gao, J., Huo, L., Sun, X., Liu, M., Li, D., Dong, J., & Zhou, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708470200 · Cited by 128
Wang, Y., Li, L., Han, K.-J., Zhai, Z., & Shu, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.071 · Cited by 124
Sato, S., Sanjo, H., Tsujimura, T., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Takeuchi, O., & Akira, S. (2006) · International Immunology · doi:10.1093/intimm/dxl082 · Cited by 123
The Role of Ubiquitin C-Terminal Hydrolase L1 in Neurodegenerative Disorders
Gong, B., & Leznik, E. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.6.1138160 · Cited by 121
Mouchantaf, R., Azakir, B., McPherson, P. S., Millard, S. M., Wood, S. A., & Angers, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605959200 · Cited by 119
TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD
Stokes, A. J., Wakano, C., Koblan‐Huberson, M., Adra, C. N., Fleig, A., & Turner, H. C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.12.009 · Cited by 119
Tumor Suppressor CYLD Regulates JNK-Induced Cell Death in Drosophila
Xue, L., Igaki, T., Kuranaga, E., Kanda, H., Miura, M., & Xu, T. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.07.012 · Cited by 112
Molecular mechanisms for adaptive tolerance and other T cell anergy models
Choi, S., & Schwartz, R. H. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.005 · Cited by 112
The CAP-Gly Domain of CYLD Associates with the Proline-Rich Sequence in NEMO/IKKγ
Saito, K., Kigawa, T., Koshiba, S., Sato, K. Z., Matsuo, Y., Sakamoto, A., Takagi, T., Shirouzu, M., Yabuki, T., Nunokawa, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.07.012 · Cited by 106
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
Hövelmeyer, N., Wunderlich, F. T., Massoumi, R., Jakobsen, C. G., Song, J., Wörns, M., Merkwirth, C., Kovalenko, A., Aumailley, M., Strand, D. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070318 · Cited by 104
A Human Suppressor of c-Jun N-terminal Kinase 1 Activation by Tumor Necrosis Factor α
Jin, D., Teramoto, H., Giam, C., Chun, R. F., Gutkind, J. S., & Jeang, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25816 · Cited by 102
Thien, C. B. F., Bowtell, D. D. L., & Langdon, W. Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7133 · Cited by 95
Isolation and characterization of two novel A20-like proteins
Evans, P. C., TAYLOR, E. R., Coadwell, J., Heyninck, K., Beyaert, R., & Kilshaw, P. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570617 · Cited by 89
Gatot, J., Gioia, R., Chau, T., Patrascu, F., Warnier, M., Close, P., Chapelle, J.-P., Muraille, É., Brown, K., Siebenlist, U. K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701690200 · Cited by 85
Cutting Edge: Pivotal Function of Ubc13 in Thymocyte TCR Signaling
Yamamoto, M., Sato, S., Saitoh, T., Sakurai, H., Uematsu, S., Kawai, T., Ishii, K. J., Takeuchi, O., & Akira, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7520 · Cited by 84
Lim, J. H., Jono, H., Koga, T., Woo, C.-H., Ishinaga, H., Bourne, P. A., Xu, H., Ha, U., Xu, H., & Li, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001032 · Cited by 83
Jin, W., Reiley, W. W., Lee, A. J., Wright, A., Wu, X., Zhang, M., & Sun, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609952200 · Cited by 77
Self-citationMacKenzie, D. A., Schartner, J. M., Lin, J. T., Timmel, A., Jennens-Clough, M. L., Fathman, C. G., & Seroogy, C. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604192200 · Cited by 70
The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells
Lin, A. E., & Mak, T. W. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.002 · Cited by 69
The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance
Liu, Y. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.003 · Cited by 60
Thiefes, A., Wolf, A., Doerrie, A., Graßl, G. A., Matsumoto, K., Autenrieth, I. B., Bohn, E., Sakurai, H., Niedenthal, R. K., Resch, K., et al. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400754 · Cited by 55
Migone, T., Humbert, M., Rascle, A., Sanden, D., D’Andrea, A. D., & Johnston, J. A. (2001) · Blood · doi:10.1182/blood.v98.6.1935 · Cited by 49
Hawash, I. Y., Geahlen, R. L., Harrison, M. L., Kesavan, K. P., & Magee, A. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110002200 · Cited by 45
Cytokine-Regulated Protein Degradation by the Ubiquitination System
Baek, K. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306776359740 · Cited by 44
Cited by
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,135
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
New regulators of NF-κB in inflammation
Ghosh, S., & Hayden, M. S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2423 · Cited by 1,334
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Chen, Z. J., & Sun, L. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.014 · Cited by 923
Metadata
- Authors
- Sun, S.-C.
- Venue
- Nature Reviews Immunology
- Published
- 2008-07
- Volume
- 8
- Issue
- 7
- Pages
- 501-511
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2005739512
- Cited by
- 355
- References
- 112
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.